1.
|
Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: I99006, NCT00199602
|
|
2.
|
Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and 120
Sponsor: Pharmaceutical / Industry
Protocol IDs: IN 0901 INT, 2009-018141-20, NCT01130025
|
|
3.
|
Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: EudraCT nr: 2009-015336-15, Protocol nr: 29462, NCT01164046
|
|
4.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: RV-MM-PI-0345, NCT01380106
|
|
5.
|
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PXD101-CLN-20, NCT01317927
|
|
6.
|
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 to 60
Sponsor: Pharmaceutical / Industry
Protocol IDs: 9763, H6Q-MC-JCAX, NCT01388335
|
|
7.
|
Phase: Phase I
Type: Biomarker/Laboratory analysis
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ARQ197-A-U158, NCT01517399
|
|
8.
|
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Genetics
Status: Approved-not yet active
Age: 21 and over
Sponsor: Other
Protocol IDs: PK03/32/09, NCT01050920
|
Mobile | Español
